Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. May 23 2022 Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
2. May 19 2022 Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference
3. May 17 2022 MySugarWatch Continues Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor Commencing Direct-to-Consumer Campaign in Daily Mail
4. May 3 2022 MySugarWatch Launches Physician-Focused Ads in MIMS As Part of Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor